LAMISIL Side Effects

7023118-6 | Abortion Spontaneous
on Sep 22, 2010 Female patient from IRELAND , 38 years of age, weighting 158.7 lb, was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Lamisil dosage: .

7018070-3 | Blood Creatine Phosphokinase Increased, Dizziness, Fatigue, Hemiparesis, Insomnia, Malaise, Movement Disorder, Musculoskeletal Pain
Patient was taking Lamisil (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dizziness (What is dizziness?), fatigue, hemiparesis, insomnia, malaise, movement disorder (What is movement disorder?), musculoskeletal pain on Sep 21, 2010 from JAPAN Additional patient health information: Male patient , weighting 130.1 lb, was diagnosed with onychomycosis and. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with PEKIRON (View Pekiron Review and Pekiron Label ), BIOFERMIN (3 Df) (View Biofermin Review and Biofermin Label ), UREPEARL (Unk) (View Urepearl Review and Urepearl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), SHAKUYAKUKANZOUTOU (2.5 Gram) (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

7015399-X | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Cellulitis, Dehydration, Rhabdomyolysis
Adverse event was reported on Sep 16, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: ) was diagnosed with onychomycosis and. Location: JAPAN , 78 years of age, After Lamisil was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, cellulitis (What is cellulitis?), dehydration, rhabdomyolysis. Patient was hospitalized.

7015395-2 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Blood Lactate Dehydrogenase Increased, Liver Function Test Abnormal, Myalgia, Rhabdomyolysis
on Sep 16, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with onychomycosis, hypertension and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactate dehydrogenase increased, liver function test abnormal, myalgia, rhabdomyolysis. Lamisil dosage: Unk. During the same period patient was treated with EXFORGE (View Exforge Review and Exforge Label ).


7009488-3 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Cellulitis, Dehydration, Rhabdomyolysis
on Sep 10, 2010 Female patient from JAPAN , 78 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, cellulitis (What is cellulitis?), dehydration, rhabdomyolysis. Lamisil dosage: . Patient was hospitalized.

7005125-2 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Blood Lactate Dehydrogenase Increased, Liver Function Test Abnormal, Myalgia, Rhabdomyolysis
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactate dehydrogenase increased, liver function test abnormal, myalgia, rhabdomyolysis on Sep 15, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, was diagnosed with onychomycosis, hypertension and. Lamisil dosage: Unk. During the same period patient was treated with EXFORGE (View Exforge Review and Exforge Label ).

7005067-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Cognitive Disorder, Delusion, Dysphagia, Gamma-glutamyltransferase Increased
Adverse event was reported on Sep 09, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 125 Mg/day) was diagnosed with onychomycosis, reflux oesophagitis, epilepsy (What is epilepsy?), hypothyroidism, atrial fibrillation (What is atrial fibrillation?), cardiac failure chronic, angina pectoris and. Location: JAPAN , weighting 79.37 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood bilirubin increased, blood creatine phosphokinase increased, cognitive disorder, delusion, dysphagia, gamma-glutamyltransferase increased. During the same period patient was treated with FAMOTIDINE (20 Mg) (View Famotidine Review and Famotidine Label ), EXCEGRAN (300 Mg) (View Excegran Review and Excegran Label ), PHENOBARBITAL SODIUM 100MG CAP (1 G) (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), THYRADIN S (100 Ug) (View Thyradin S Review and Thyradin S Label ), LANIRAPID (0.05 Mg) (View Lanirapid Review and Lanirapid Label ), CYTARABINE (25 Mg) (View Cytarabine Review and Cytarabine Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), FRANDOL (40 Mg) (View Frandol Review and Frandol Label ).

7002229-5 | Ageusia, Dry Mouth, Dysgeusia, Rash
on Sep 17, 2010 Female patient from UNITED STATES , weighting 128.0 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient had the following side effects: ageusia, dry mouth, dysgeusia, rash (What is rash?). Lamisil dosage: 250 Mg Once Daily.

6980552-8 | Pustular Psoriasis, Pyrexia, Rash, Rash Pustular, Skin Hypertrophy
on Sep 08, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: pustular psoriasis, pyrexia, rash (What is rash?), rash pustular, skin hypertrophy. Lamisil dosage: . During the same period patient was treated with PREDONINE (10 Mg) (View Predonine Review and Predonine Label ). Patient was hospitalized.

6980528-0 | Photodermatosis, Pruritus
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: photodermatosis, pruritus on Sep 06, 2010 from DENMARK Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with dermatophytosis and. Lamisil dosage: 250 Milligram (s). Patient was hospitalized.

6971349-3 | Hepatitis Cholestatic
Adverse event was reported on Sep 06, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 250 Mg, Qd) was diagnosed with onychomycosis and. Location: SPAIN , 54 years of age, Patient had the following side effects: hepatitis cholestatic. During the same period patient was treated with OMEPRAZOLE (20 Mg Daily) (View Omeprazole Review and Omeprazole Label ), SULPHASALAZINE (3g Daily) (View Sulphasalazine Review and Sulphasalazine Label ), DACORTIN (7.5 Mg Daily) (View Dacortin Review and Dacortin Label ), METOJECT (25 Mg, Qw) (View Metoject Review and Metoject Label ), NATECAL D (1.5 G Daily) (View Natecal D Review and Natecal D Label ). Patient was hospitalized.

6969967-1 | Cystitis, Myalgia
on Aug 31, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with onychomycosis, dyslipidaemia, hypertension and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: cystitis, myalgia. Lamisil dosage: 125 Mg, Unk. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6969211-5 | Abdominal Discomfort, Anxiety, Arthralgia, Decreased Appetite, Depression, Disturbance In Attention, Dry Mouth, Dysgeusia, Eructation
on Sep 01, 2010 Male patient from AUSTRALIA , weighting 176.4 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, anxiety (What is anxiety?), arthralgia, decreased appetite, depression (What is depression?), disturbance in attention, dry mouth, dysgeusia, eructation. Lamisil dosage: 250 Mg Daily. During the same period patient was treated with FISH OIL (View Fish Oil Review and Fish Oil Label ), INNER HEALTH POWDER (View Inner Health Powder Review and Inner Health Powder Label ), ST. JOHN'S WORT (View St. John's Wort Review and St. John's Wort Label ).

6969190-0 | Abortion Spontaneous
Patient was taking Lamisil (View Usage). Patient had the following side effects: abortion spontaneous on Aug 31, 2010 from IRELAND Additional patient health information: Female patient , 38 years of age, weighting 158.7 lb, . Lamisil dosage: .

6963858-8 | Blood Creatine Phosphokinase Increased, Dizziness, Dysarthria, Dysphagia, Fatigue, Hemiparesis, Insomnia, Malaise
Adverse event was reported on Aug 24, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) was diagnosed with onychomycosis and. Location: JAPAN , weighting 130.1 lb, After Lamisil was administered, patient had the following side effects: blood creatine phosphokinase increased, dizziness (What is dizziness?), dysarthria, dysphagia, fatigue, hemiparesis, insomnia, malaise. During the same period patient was treated with PEKIRON (View Pekiron Review and Pekiron Label ), BIOFERMIN (3 Df) (View Biofermin Review and Biofermin Label ), UREPEARL (Unk) (View Urepearl Review and Urepearl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), SHAKUYAKUKANZOUTOU (2.5 Gram) (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6961414-9 | Abortion Spontaneous
on Aug 23, 2010 Female patient from IRELAND , 38 years of age, weighting 158.7 lb, was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Lamisil dosage: .

6958787-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Asthma, Blood Bilirubin Increased, Blood Creatine Phosphokinase Increased, Cognitive Disorder, Delusion, Gamma-glutamyltransferase Increased
on Aug 19, 2010 Female patient from JAPAN , weighting 79.37 lb, was diagnosed with reflux oesophagitis, epilepsy (What is epilepsy?), hypothyroidism, atrial fibrillation (What is atrial fibrillation?), cardiac failure chronic, angina pectoris and was treated with Lamisil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, asthma (What is asthma?), blood bilirubin increased, blood creatine phosphokinase increased, cognitive disorder, delusion, gamma-glutamyltransferase increased. Lamisil dosage: 125 Mg/day. During the same period patient was treated with FAMOTIDINE (20 Mg) (View Famotidine Review and Famotidine Label ), EXCEGRAN (300 Mg) (View Excegran Review and Excegran Label ), PHENOBARBITAL SODIUM 100MG CAP (1 G) (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), THYRADIN S (100 Ug) (View Thyradin S Review and Thyradin S Label ), LANIRAPID (0.05 Mg) (View Lanirapid Review and Lanirapid Label ), CYTARABINE (25 Mg) (View Cytarabine Review and Cytarabine Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), FRANDOL (40 Mg) (View Frandol Review and Frandol Label ).

6958725-X | Cystitis, Myalgia
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: cystitis, myalgia on Aug 18, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with dyslipidaemia, hypertension and. Lamisil dosage: 125 Mg, Unk. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6942415-3 | Blood Bilirubin Increased, Granuloma
Adverse event was reported on Aug 23, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: ) . Location: JAPAN , 90 years of age, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, granuloma.

6938707-4 | Anxiety, Decreased Appetite, Depressed Mood, Dysgeusia, Weight Decreased
on Aug 11, 2010 Female patient from HONG KONG , weighting 105.8 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient had the following side effects: anxiety (What is anxiety?), decreased appetite, depressed mood, dysgeusia, weight decreased. Lamisil dosage: 250 Mg, Qd.

6935824-X | Blood Creatine Phosphokinase Increased, Dizziness, Dysarthria, Dysphagia, Fatigue, Hemiparesis, Insomnia, Malaise
on Aug 10, 2010 Male patient from JAPAN , weighting 130.1 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: blood creatine phosphokinase increased, dizziness (What is dizziness?), dysarthria, dysphagia, fatigue, hemiparesis, insomnia, malaise. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with PEKIRON (View Pekiron Review and Pekiron Label ), BIOFERMIN (3 Df) (View Biofermin Review and Biofermin Label ), UREPEARL (View Urepearl Review and Urepearl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), SHAKUYAKUKANZOUTOU (2.5 Gram) (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6922609-3 | Abdominal Distension, Abdominal Pain, Abdominal Pain Upper, Constipation, Gastritis, Skin Warm
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), abdominal pain upper, constipation (What is constipation?), gastritis, skin warm on Jul 30, 2010 from MEXICO Additional patient health information: Female patient , 60 years of age, weighting 121.3 lb, was diagnosed with onychomycosis and. Lamisil dosage: 250 Mg Daily.

6922603-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Cholesterol Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
Adverse event was reported on Jul 30, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: Unk) was diagnosed with psoriasis, seborrhoeic dermatitis and. Location: JAPAN , 39 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholesterol increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder.

6918698-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Asthenia, Asthma, Blood Creatine Phosphokinase Increased, Gamma-glutamyltransferase Increased, Malaise, Myalgia, Myoglobin Blood Increased
on Jul 29, 2010 Female patient from JAPAN , 96 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, asthma (What is asthma?), blood creatine phosphokinase increased, gamma-glutamyltransferase increased, malaise, myalgia, myoglobin blood increased. Lamisil dosage: 125 Mg, Unk. During the same period patient was treated with FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), EXCEGRAN (Unk) (View Excegran Review and Excegran Label ), PHENOBARBITAL SODIUM 100MG CAP (Unk) (View Phenobarbital Sodium 100mg Cap Review and Phenobarbital Sodium 100mg Cap Label ), THYRADIN S (Unk) (View Thyradin S Review and Thyradin S Label ), LANIRAPID (Unk) (View Lanirapid Review and Lanirapid Label ), CYTARABINE (Unk) (View Cytarabine Review and Cytarabine Label ), LASIX (Unk) (View Lasix Review and Lasix Label ), FRANDOL (Unk) (View Frandol Review and Frandol Label ).

6911768-4 | Bronchial Disorder, Cheilitis, Chills, Conjunctival Hyperaemia, Conjunctivitis, Cytolytic Hepatitis, Dermatitis Exfoliative
on Jan 09, 2008 Female patient from FRANCE , 54 years of age, was diagnosed with onychomycosis, back pain (What is back pain?) and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: bronchial disorder, cheilitis, chills, conjunctival hyperaemia, conjunctivitis, cytolytic hepatitis, dermatitis exfoliative. Lamisil dosage: 250 Mg, Qd. During the same period patient was treated with LAMICTAL (200 Mg, Unk) (View Lamictal Review and Lamictal Label ), PROPOFAN (View Propofan Review and Propofan Label ), EFFERALGAN (View Efferalgan Review and Efferalgan Label ), PARACETAMOL (Unk, Unk) (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6907881-8 | Eczema, Erythema Multiforme, Mycotic Allergy, Pruritus, Skin Lesion
Patient was taking Lamisil (View Usage). Patient had the following side effects: eczema (What is eczema?), erythema multiforme, mycotic allergy, pruritus, skin lesion on Jul 22, 2010 from GERMANY Additional patient health information: Male patient , 22 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Lamisil dosage: .

6900364-0 | Chromaturia, Gallbladder Polyp, Surgery
Adverse event was reported on Jul 22, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) . Location: JAPAN , 72 years of age, After Lamisil was administered, patient had the following side effects: chromaturia, gallbladder polyp, surgery (What is surgery?). Patient was hospitalized.

6894557-9 | Asthenia, Asthma, Blood Creatine Phosphokinase Increased, Myalgia, Myoglobin Blood Increased, Rhabdomyolysis, Sciatica
on Jul 20, 2010 Female patient from JAPAN , 96 years of age, was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, asthma (What is asthma?), blood creatine phosphokinase increased, myalgia, myoglobin blood increased, rhabdomyolysis, sciatica (What is sciatica?). Lamisil dosage: 125 Mg, Unk.

6877874-8 | Cystitis, Myalgia
on Jul 14, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with dyslipidaemia, hypertension and was treated with Lamisil (View Usage). Patient had the following side effects: cystitis, myalgia. Lamisil dosage: 125 Mg, Unk. During the same period patient was treated with LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6870719-1 | Abdominal Pain, Burning Sensation
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), burning sensation on Jun 22, 2010 from DOMINICAN REPUBLIC Additional patient health information: Male patient , 60 years of age, was diagnosed with onychomycosis and. Lamisil dosage: 250 Mg, Unk.

6866530-8 | Aspartate Aminotransferase Increased, Liver Disorder
Adverse event was reported on Jul 09, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) . Location: JAPAN , 70 years of age, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, liver disorder.

6861989-4 | Blood Creatine Phosphokinase Increased, Dizziness, Fatigue, Hemiparesis, Illiteracy, Insomnia, Malaise, Movement Disorder
on Jul 07, 2010 Male patient from JAPAN , 77 years of age, weighting 130.1 lb, was diagnosed with onychomycosis, hypertension and was treated with Lamisil (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dizziness (What is dizziness?), fatigue, hemiparesis, illiteracy, insomnia, malaise, movement disorder (What is movement disorder?). Lamisil dosage: 125 Mg Daily. During the same period patient was treated with PEKIRON (View Pekiron Review and Pekiron Label ), CALSLOT (20 Mg) (View Calslot Review and Calslot Label ), BIOFERMIN (3 Df) (View Biofermin Review and Biofermin Label ), UREPEARL (View Urepearl Review and Urepearl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), SHAKUYAKUKANZOUTOU (2.5 Gram) (View Shakuyakukanzoutou Review and Shakuyakukanzoutou Label ).

6843852-8 | Hepatic Function Abnormal, Pneumonia
on Jul 02, 2010 Female patient from JAPAN , weighting 127.9 lb, was diagnosed with back pain (What is back pain?), gastritis, cancer pain, anxiety disorder, plasmacytoma, reflux oesophagitis, constipation (What is constipation?) and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: hepatic function abnormal, pneumonia (What is pneumonia?). Lamisil dosage: 125 Mg Daily. During the same period patient was treated with TIZANIDINE HCL (3 Mg Daily) (View Tizanidine Hcl Review and Tizanidine Hcl Label ), MOBIC (10 Mg Daily) (View Mobic Review and Mobic Label ), GASMOTIN (15 Mg Daily) (View Gasmotin Review and Gasmotin Label ), MEXILETINE HYDROCHLORIDE (150 Mg Daily) (View Mexiletine Hydrochloride Review and Mexiletine Hydrochloride Label ), SERENAL (10 Mg Daily) (View Serenal Review and Serenal Label ), PREDNISOLONE (5 Mg) (View Prednisolone Review and Prednisolone Label ), GASPORT (40 Mg) (View Gasport Review and Gasport Label ), MAGNESIUM OXIDE (1980 Mg) (View Magnesium Oxide Review and Magnesium Oxide Label ).

6843822-X | Photodermatosis, Pruritus
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: photodermatosis, pruritus on Jul 01, 2010 from DENMARK Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with dermatophytosis and. Lamisil dosage: 250 Milligram (s). Patient was hospitalized.

6840248-X | Blood Viscosity Increased, Cardiac Disorder, Cough, Dyskinesia, Dyspnoea, Fatigue, Feeling Abnormal, Influenza
Adverse event was reported on Jul 08, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 250 Mg) was diagnosed with onychomycosis and. Location: NETHERLANDS , weighting 132.3 lb, Patient had the following side effects: blood viscosity increased, cardiac disorder, cough, dyskinesia, dyspnoea, fatigue, feeling abnormal, influenza.

6840199-0 | Asthenia, Dehydration, Emotional Disorder, Headache, Oropharyngeal Pain
on Jul 13, 2010 Female patient from UNITED STATES , 45 years of age, weighting 175.3 lb, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: asthenia, dehydration, emotional disorder, headache (What is headache?), oropharyngeal pain. Lamisil dosage: 1 Daily Oral.

6765880-3 | Antepartum Haemorrhage
on Jun 02, 2010 Female patient from FRANCE , 29 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: antepartum haemorrhage. Lamisil dosage: 250 Mg, Qd. During the same period patient was treated with LOBAMINE CYSTEINE (View Lobamine-cysteine Review and Lobamine-cysteine Label ).

6765558-6 | Asthenia, Body Temperature Increased, Decreased Appetite, Pancytopenia, Red Blood Cell Count Decreased, Thrombocytopenia, White Blood Cell Count Increased
Patient was taking Lamisil (View Usage). Patient had the following side effects: asthenia, body temperature increased, decreased appetite, pancytopenia, red blood cell count decreased, thrombocytopenia, white blood cell count increased on Jun 08, 2010 from JAPAN Additional patient health information: Female patient , weighting 83.78 lb, was diagnosed with tinea infection (What is tinea infection?), constipation (What is constipation?), osteoporosis (What is osteoporosis?) and. Lamisil dosage: Unk. During the same period patient was treated with INTENURSE (Unk) (View Intenurse Review and Intenurse Label ), FLUTICASONE PROPIONATE W/SALMETEROL XINAFOATE (Unk) (View Fluticasone Propionate W/salmeterol Xinafoate Review and Fluticasone Propionate W/salmeterol Xinafoate Label ), BUP 4 (20 Mg, Unk) (View Bup-4 Review and Bup-4 Label ), FORSENID (24 Mg, Unk) (View Forsenid Review and Forsenid Label ), ASPARA CA (400 Mg) (View Aspara-ca Review and Aspara-ca Label ), MAGLAX (660 Mg, Unk) (View Maglax Review and Maglax Label ), MUCOSTA (200 Mg, Unk) (View Mucosta Review and Mucosta Label ), NICHI E NATE (200 Mg, Unk) (View Nichi E-nate Review and Nichi E-nate Label ). Patient was hospitalized.

6755948-X | Feeling Abnormal, Malaise, Nail Pigmentation
Adverse event was reported on May 19, 2010 by a Male patient taking Lamisil (View Usage) (Dosage: 125 Mg Daily) was diagnosed with onychomycosis and. Location: JAPAN , 42 years of age, After Lamisil was administered, patient had the following side effects: feeling abnormal, malaise, nail pigmentation. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE (Unk) (View Butenafine Hydrochloride Review and Butenafine Hydrochloride Label ).

6748786-5 | Anxiety, Depression, Feeling Abnormal, Malaise, Mental Disorder, Suicidal Ideation
on May 20, 2010 Male patient from AUSTRALIA , weighting 176.4 lb, was diagnosed with onychomycosis, depression (What is depression?), anxiety (What is anxiety?) and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), depression (What is depression?), feeling abnormal, malaise, mental disorder, suicidal ideation. Lamisil dosage: 250 Mg. During the same period patient was treated with ZOLOFT (Unk) (View Zoloft Review and Zoloft Label ).

6748766-X | Feeling Abnormal, Haemorrhage, Malaise, Nail Pigmentation, Platelet Count Decreased
on May 19, 2010 Male patient from JAPAN , 42 years of age, was diagnosed with onychomycosis and was treated with Lamisil (View Usage). Patient had the following side effects: feeling abnormal, haemorrhage, malaise, nail pigmentation, platelet count decreased. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE (Unk) (View Butenafine Hydrochloride Review and Butenafine Hydrochloride Label ).

6737930-1 | Feeling Abnormal, Haemorrhage, Nail Pigmentation, Platelet Count Decreased
Patient was taking Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: feeling abnormal, haemorrhage, nail pigmentation, platelet count decreased on Apr 26, 2010 from JAPAN Additional patient health information: Male patient , 42 years of age, was diagnosed with onychomycosis and. Lamisil dosage: 125 Mg Daily. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE (View Butenafine Hydrochloride Review and Butenafine Hydrochloride Label ).

6737773-9 | Hyperthermia, Infection, Inflammation, Pruritus, Rash Erythematous, Septic Shock, Skin Exfoliation, Skin Lesion
Adverse event was reported on May 20, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: 250 Mg, Qd) . Location: FRANCE , 14 years of age, Patient experienced the following unwanted or unexpected effects: hyperthermia, infection (What is infection?), inflammation, pruritus, rash erythematous, septic shock, skin exfoliation, skin lesion. During the same period patient was treated with IMIPENEM AND CILASTATIN (450 Mg, Bid) (View Imipenem And Cilastatin Review and Imipenem And Cilastatin Label ), VANCOMYCIN (450 Mg, Bid) (View Vancomycin Review and Vancomycin Label ), ZOVIRAX (150 Mg, Tid) (View Zovirax Review and Zovirax Label ), ZOLOFT (Unk) (View Zoloft Review and Zoloft Label ), ANCOTIL (Unk) (View Ancotil Review and Ancotil Label ), BACTRIM (Unk) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6737767-3 | Asthenia, Body Temperature Increased, Decreased Appetite, Pancytopenia, Thrombocytopenia, White Blood Cell Count Increased
on May 18, 2010 Female patient from JAPAN , weighting 83.78 lb, was diagnosed with tinea infection (What is tinea infection?), constipation (What is constipation?), osteoporosis (What is osteoporosis?) and was treated with Lamisil (View Usage). Patient had the following side effects: asthenia, body temperature increased, decreased appetite, pancytopenia, thrombocytopenia, white blood cell count increased. Lamisil dosage: Unk. During the same period patient was treated with FLUTICASONE PROPIONATE W/SALMETEROL XINAFOATE (Unk) (View Fluticasone Propionate W/salmeterol Xinafoate Review and Fluticasone Propionate W/salmeterol Xinafoate Label ), BUP 4 (20 Mg) (View Bup-4 Review and Bup-4 Label ), FORSENID (24 Mg) (View Forsenid Review and Forsenid Label ), ASPARA CA (400 Mg) (View Aspara-ca Review and Aspara-ca Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), NICHI E NATE (Unk) (View Nichi E-nate Review and Nichi E-nate Label ). Patient was hospitalized.

6737723-5 | Haematemesis, Nail Growth Abnormal, Small Intestinal Haemorrhage
on May 12, 2010 Male patient from JAPAN , 76 years of age, was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: haematemesis, nail growth abnormal, small intestinal haemorrhage. Lamisil dosage: Unk. During the same period patient was treated with AMLODIPINE BESYLATE (Unk) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FLUVASTATIN (Unk) (View Fluvastatin Review and Fluvastatin Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ). Patient was hospitalized.

6715900-7 | Infarction
Patient was taking Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: infarction on Apr 27, 2010 from MEXICO Additional patient health information: Male patient , 74 years of age, was diagnosed with onychomycosis, hypertension and. Lamisil dosage: 250 Mg, Per Day.

6698847-4 | Leukaemia, Pancytopenia
Adverse event was reported on Apr 23, 2010 by a Female patient taking Lamisil (View Usage) (Dosage: Unk) . Location: JAPAN , 81 years of age, Patient had the following side effects: leukaemia, pancytopenia. During the same period patient was treated with FLUTICASONE PROPIONATE W/SALMETEROL XINAFOATE (Unk) (View Fluticasone Propionate W/salmeterol Xinafoate Review and Fluticasone Propionate W/salmeterol Xinafoate Label ), BUP 4 (Unk) (View Bup-4 Review and Bup-4 Label ), FORSENID (Unk) (View Forsenid Review and Forsenid Label ), ASPARA CA (Unk) (View Aspara-ca Review and Aspara-ca Label ), MAGLAX (Unk) (View Maglax Review and Maglax Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), NICHI E NATE (Unk) (View Nichi E-nate Review and Nichi E-nate Label ). Patient was hospitalized.

6697415-8 | Erysipelas
on Oct 27, 2009 Male patient from BRAZIL , 61 years of age, weighting 180.8 lb, was diagnosed with onychomycosis, tinea pedis and was treated with Lamisil (View Usage). After Lamisil was administered, patient had the following side effects: erysipelas. Lamisil dosage: Unk.

6690123-9 | Blood Pressure Increased
on Apr 15, 2010 Male patient from BRAZIL , 34 years of age, weighting 198.4 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Lamisil (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Lamisil dosage: Unk, Twice Daily.

6664243-9 | Epilepsy
Patient was taking Lamisil (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?) on Mar 22, 2010 from FRANCE Additional patient health information: Male patient , weighting 231.5 lb, was diagnosed with epilepsy (What is epilepsy?), hypercholesterolaemia and. Lamisil dosage: 250 Mg, Bid. During the same period patient was treated with LAMICTAL CD (200 Mg, Bid) (View Lamictal Cd Review and Lamictal Cd Label ), FENOFIBRATE (145 Mg, Unk) (View Fenofibrate Review and Fenofibrate Label ), URBANYL (Unk) (View Urbanyl Review and Urbanyl Label ).